Top Clinical Trials companies in the world by Free Cash Flow

This ranking features the top 400 Clinical Trials companies in the world ranked by Free Cash Flow, totalling a Free Cash Flow of USD -19.10 B, for January 15, 2025.

Global

Clinical Trials

#	Name	Free Cash Flow	Reported Date	Stock Price	Change	Country
1	BioNTech SE 1 22UA.F	USD 5.15 B	Dec. 31, 2023	USD 116.36	-0.45%	Germany
2	Genmab A/S 2 GMAB.CO	USD 1.04 B	Dec. 31, 2023	USD 216.88	1.28%	Denmark
3	ICON Public Limited Company 3 ICLR	USD 1.02 B	Dec. 31, 2023	USD 200.24	-8.14%	Ireland
4	Charles River Laboratories International, Inc. 4 CRL	USD 560.48 M	Sept. 28, 2024	USD 178.08	-6.34%	United States
5	Medpace Holdings, Inc. 5 MEDP	USD 535.65 M	Sept. 30, 2024	USD 330.91	-5.99%	United States
6	Neurocrine Biosciences, Inc. 6 NBIX	USD 440.10 M	Sept. 30, 2024	USD 139.51	-2.46%	United States
7	Exelixis, Inc. 7 EXEL	USD 423.19 M	Sept. 27, 2024	USD 35.65	0.99%	United States
8	Protagonist Therapeutics, Inc. 8 PTGX	USD 229.23 M	Sept. 30, 2024	USD 36.67	-1.26%	United States
9	Akeso, Inc. 9 9926.HK	USD 223.71 M	Dec. 31, 2023	USD 7.28	2.32%	China
10	HUTCHMED (China) Limited 10 0013.HK	USD 186.65 M	Dec. 31, 2023	USD 3.02	2.59%	Hong Kong
11	Supernus Pharmaceuticals, Inc. 11 SUPN	USD 172.03 M	Sept. 30, 2024	USD 37.82	0.66%	United States
12	Corcept Therapeutics Incorporated 12 CORT	USD 142.60 M	Sept. 30, 2024	USD 51.66	1.18%	United States
13	Hua Medicine (Shanghai) Ltd. 13 2552.HK	USD 123.88 M	Dec. 31, 2023	USD 0.17	-0.02%	China
14	Hangzhou Tigermed Consulting Co., Ltd. 14 3347.HK	USD 117.85 M	Dec. 31, 2023	USD 3.72	2.09%	China
15	Australian Clinical Labs Limited 15 ACL.AX	USD 102.07 M	June 30, 2024	USD 2.14	0.82%	Australia
16	Joinn Laboratories(China)Co.,Ltd. 16 6127.HK	USD 60.59 M	Dec. 31, 2023	USD 1.06	2.98%	China
17	Krystal Biotech, Inc. 17 KRYS	USD 58.06 M	Sept. 30, 2024	USD 142.64	-5.10%	United States
18	Castle Biosciences, Inc. 18 CSTL	USD 40.03 M	Sept. 30, 2024	USD 25.46	-2.64%	United States
19	GNI Group Ltd. 19 2160.T	USD 31.70 M	Dec. 31, 2023	USD 19.77	1.11%	Japan
20	BioArctic AB (publ) 20 BIOA-B.ST	USD 29.83 M	Dec. 31, 2023	USD 17.87	3.09%	Sweden
21	Xencor, Inc. 21 XNCR	USD 26.06 M	Sept. 30, 2024	USD 19.11	-5.68%	United States
22	ProQR Therapeutics N.V. 22 PRQR	USD 22.27 M	Dec. 31, 2023	USD 2.26	-0.44%	Netherlands
23	Mega Genomics Limited 23 6667.HK	USD 17.97 M	Dec. 31, 2023	USD 1.18	-0.89%	China
24	Incyte Corporation 24 INCY	USD 16.80 M	Sept. 30, 2024	USD 71.93	-0.61%	United States
25	Alnylam Pharmaceuticals, Inc. 25 ALNY	USD 16.06 M	Sept. 30, 2024	USD 240.51	-6.88%	United States
26	hVIVO plc 26 HVO.L	USD 15.35 M	Dec. 31, 2023	USD 0.21	6.16%	United Kingdom
27	Alar Pharmaceuticals Inc. 27 6785.TWO	USD 12.94 M	Dec. 31, 2023	USD 4.09	5.18%
28	Rigel Pharmaceuticals, Inc. 28 RIGL	USD 10.61 M	Sept. 30, 2024	USD 16.69	-2.46%	United States
29	Telix Pharmaceuticals Limited 29 TLX.AX	USD 8.91 M	Dec. 31, 2023	USD 15.47	4.25%	Australia
30	Shanghai Henlius Biotech, Inc. 30 2696.HK	USD 5.14 M	Dec. 31, 2023	USD 2.59	-10.24%	China
31	Arcellx, Inc. 31 ACLX	USD 3.58 M	Sept. 30, 2024	USD 64.65	-4.02%	United States
32	Ovoca Bio plc 32 OVB.L	USD 1.18 M	Dec. 31, 2023	USD 0.02	-6.17%	Ireland
33	Cardiol Therapeutics Inc. 33 CRDL.TO	USD -19.05 K	Dec. 31, 2023	USD 1.25	-1.98%	Canada
34	Pila Pharma AB (publ) 34 PILA.ST	USD -479.09 K	Dec. 31, 2023	USD 0.39	2.53%	Sweden
35	PhoenixBio Co., Ltd. 35 6190.T	USD -780.15 K	March 31, 2024	USD 2.06	-4.87%	Japan
36	Corline Biomedical AB 36 CLBIO.ST	USD -960.84 K	Dec. 31, 2023	USD 0.84	-0.17%	Sweden
37	TaiMed Biologics Inc. 37 4147.TWO	USD -1.03 M	Dec. 31, 2023	USD 2.64	-2.78%	Taiwan
38	ImmuPharma plc 38 IMM.L	USD -1.74 M	Dec. 31, 2023	USD 0.04	-14.59%	United Kingdom
39	ViroGates A/S 39 VIRO.CO	USD -1.80 M	Dec. 31, 2023	USD 1.93	-6.19%	Denmark
40	Vimta Labs Limited 40 VIMTALABS.NS	USD -1.88 M	March 31, 2024	USD 10.54	-1.07%	India
41	Aptahem AB (publ) 41 APTA.ST	USD -2.29 M	Dec. 31, 2023	USD 0.11	1.51%	Sweden
42	Great Novel Therapeutics Biotech & Medicals 42 7427.TWO	USD -2.42 M	Dec. 31, 2023	USD 0.96	-1.13%
43	Immunocore Holdings plc 43 IMCR	USD -2.48 M	Dec. 31, 2023	USD 28.56	-4.90%	United Kingdom
44	180 Life Sciences Corp. 44 ATNF	USD -2.69 M	Sept. 30, 2024	USD 1.56	4.70%	United States
45	Psyence Biomedical Ltd. 45 PBM	USD -2.95 M	March 31, 2024	USD 1.82	-9.45%	Canada
46	CombiGene AB (publ) 46 COMBI.ST	USD -3.03 M	Dec. 31, 2023	USD 0.21	0.68%	Sweden
47	SymBio Pharmaceuticals Limited 47 4582.T	USD -3.03 M	Dec. 31, 2023	USD 1.27	-1.66%	Japan
48	Lipum AB (publ) 48 LIPUM.ST	USD -3.58 M	Dec. 31, 2023	USD 1.17	-3.73%	Sweden
49	NextCell Pharma AB 49 NXTCL.ST	USD -3.67 M	Aug. 31, 2024	USD 0.22	-6.29%	Sweden
50	Prostatype Genomics AB (publ) 50 PROGEN.ST	USD -3.72 M	Dec. 31, 2023	USD 0.80	0.68%	Sweden

1 2 3 4 … 8

Frequently Asked Questions

Which Clinical Trials company has the highest Free Cash Flow ?

The Clinical Trials company with the highest Free Cash Flow is BioNTech SE (Frankfurt Stock Exchange: 22UA.F) at USD 5.15 B.
Which Clinical Trials company has the lowest Free Cash Flow ?

The Clinical Trials company with the lowest Free Cash Flow is InMed Pharmaceuticals Inc. (NasdaqCM: INM) at USD -1.83 B.

What are the top 10 Clinical Trials companies by Free Cash Flow ?

The top 10 Clinical Trials companies the Global by Free Cash Flow are BioNTech SE, Genmab A/S, ICON Public Limited Company, Charles River Laboratories International, Inc., Medpace Holdings, Inc., Neurocrine Biosciences, Inc., Exelixis, Inc., Protagonist Therapeutics, Inc., Akeso, Inc. and HUTCHMED (China) Limited.
What are the bottom 10 Clinical Trials companies by Free Cash Flow ?

The bottom 10 Clinical Trials companies by Free Cash Flow are InMed Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Arrowhead Pharmaceuticals, Inc., Revolution Medicines, Inc., Biohaven Pharmaceutical Holding Company Ltd., Sarepta Therapeutics, Inc., Madrigal Pharmaceuticals, Inc., ImmunityBio, Inc., Cytokinetics, Incorporated and Denali Therapeutics Inc..